2025 SOLACI Research Grant

By initiative of the board of directors (together with the research department), SOLACI is launching a research grant aimed at improving knowledge and access to endovascular treatments in Latin America.

The 2025 SOLACI Research Grant is open to any LATAM center wishing to participate. A committee composed of the SOLACI Board of Directors and representatives from SOLACI Research will evaluate the submitted proposals and determine which one(s) will be selected to receive the grant.

How to apply for the grant?

To be eligible for the grant, applicants must submit their proposals, which must meet three inclusion criteria:

  • The research must take place in Latin America.
  • Its objective must be either to improve knowledge (e.g., “Prevalence of bicuspid valve disease in patients eligible for TAVI in XXX region”) or to improve access (e.g., “Implementation of an infarction network in rural areas”).
  • The proposal must be feasible. This means that results must be presented within two years of receiving the grant and the budget must not exceed USD 15,000.

For more information, download the complete guide to correctly submit your proposal, including the required steps, documents, and formats.

Steps to follow

  1. Download and complete all required documentation:
  2. Send all attachments in a single email to research@solaci.org.
  3. Proposals will only be accepted in English.
  4. The email must be sent by the principal investigator in charge.
  5. Submit your proposal before the deadline: April 30, 2025.
  6. Final decision: to be published before May 30, 2025.

For more details, carefully read the complete guide to correctly submit the required documentation.

Important*

  • The main manuscript of the study must be published before March 2027.
  • The results must be presented in a special session at the SOLACI Congress 2026.

More articles by this author

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

SOL SOLACI performed a new procedure in Argentina using bioabsorbable stents in pulmonary branches

The SOLACI Solidarity Program carried out a new procedure on a patient from the region of Frías, in Santiago del Estero (Argentina), during October...

Venezuela 2025 Sessions | Young Interventional Cardiologists Contest

Call for Case Submissions LIII SOLACI Regional Sessions – 18th Andean Region We invite all young Latin American cardiologists to submit clinically relevant interventional cardiology cases...

See the Best Moments from the Costa Rica 2025 Sessions

Relive the most remarkable highlights of the Costa Rica 2025 Sessions, held from October 8 to 10, 2025, at the Intercontinental Hotel in San...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

AHA 2025 | CLOSURE-AF: Left Atrial Appendage Occlusion (LAAO) vs. Medical Therapy in Atrial Fibrillation with High Stroke and Bleeding Risk

Atrial fibrillation (AF) is a complex condition in which patients often present with multiple comorbidities, including high bleeding risk. Percutaneous left atrial appendage occlusion...